{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:48:05Z","timestamp":1793972885798,"version":"4.8.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":100,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Health Science and Technology Plan Project, Youth and Middle-aged Talent Training Project","award":["2021GGA006"],"award-info":[{"award-number":["2021GGA006"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82503412"],"award-info":[{"award-number":["82503412"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473009"],"award-info":[{"award-number":["82473009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Province Science and Technology Innovation Joint Fund Project","award":["2024Y9070"],"award-info":[{"award-number":["2024Y9070"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0525500\/2024ZD0525502"],"award-info":[{"award-number":["2024ZD0525500\/2024ZD0525502"]}]},{"name":"Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare","award":["No.2021(60)"],"award-info":[{"award-number":["No.2021(60)"]}]},{"name":"National Outstanding Young Physicians Talent Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02529-x","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T11:43:31Z","timestamp":1763811811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Targeting SERPINB3\u2013MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-2217","authenticated-orcid":false,"given":"Xiao-Xiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7986-7226","authenticated-orcid":false,"given":"Cheng-Ke","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chao","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4874-2589","authenticated-orcid":false,"given":"Yong-Ding","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9619-6317","authenticated-orcid":false,"given":"Zhi-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6302-0901","authenticated-orcid":false,"given":"Hao-Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3650-5791","authenticated-orcid":false,"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Quan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4801-7808","authenticated-orcid":false,"given":"Jian-Fei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-0819","authenticated-orcid":false,"given":"Hong-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6975-3583","authenticated-orcid":false,"given":"Shun-Cang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Peng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hou-Juan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Wan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7273-8301","authenticated-orcid":false,"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2568-9364","authenticated-orcid":false,"given":"Zu-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-9906","authenticated-orcid":false,"given":"Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-4497","authenticated-orcid":false,"given":"Yi-Feng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7221-7522","authenticated-orcid":false,"given":"Cheng-Yu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8207-7479","authenticated-orcid":false,"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"1","key":"2529_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2529_CR2","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1038\/s41416-022-01752-3","volume":"126","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag CJ, Arnold M, Rutherford M, Bardot A, Ferlay J, Morgan E, et al. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study. Br J Cancer. 2022;126(12):1774\u201382.","journal-title":"Br J Cancer"},{"issue":"1","key":"2529_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.gastro.2023.09.021","volume":"166","author":"Y Feng","year":"2024","unstructured":"Feng Y, Cai L, Pook M, Liu F, Chang CH, Mouti MA, et al. BRD9-SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Gastroenterology. 2024;166(1):139\u201354.","journal-title":"Gastroenterology"},{"issue":"1","key":"2529_CR4","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2(1):16022.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"2529_CR5","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186(8):1729\u201354.","journal-title":"Cell"},{"issue":"10","key":"2529_CR6","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, et al. Durvalumab with or without Tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol. 2019;5(10):1431\u20138.","journal-title":"JAMA Oncol"},{"issue":"26","key":"2529_CR7","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012;366(26):2455\u201365.","journal-title":"N Engl J Med"},{"issue":"32","key":"2529_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303814","volume":"10","author":"ZW Chen","year":"2023","unstructured":"Chen ZW, Kang FP, Xie CK, Liao CY, Li G, Wu YD, et al. A novel trojan horse nanotherapy strategy targeting the cPKM-STMN1\/TGFB1 axis for effective treatment of intrahepatic cholangiocarcinoma. Adv Sci. 2023;10(32):e2303814.","journal-title":"Adv Sci"},{"issue":"21","key":"2529_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308208","volume":"11","author":"G Li","year":"2024","unstructured":"Li G, Liao C, Chen J, Wang Z, Zhu S, Lai J, et al. Targeting the MCP-GPX4\/HMGB1 axis for effectively triggering immunogenic ferroptosis in pancreatic ductal adenocarcinoma. Adv Sci. 2024;11(21):e2308208.","journal-title":"Adv Sci"},{"issue":"1","key":"2529_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12943-024-02128-2","volume":"23","author":"CK Xie","year":"2024","unstructured":"Xie CK, Liao CY, Lin HY, Wu YD, Lu FC, Huang XX, et al. Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Mol Cancer. 2024;23(1):215.","journal-title":"Mol Cancer"},{"issue":"1","key":"2529_CR11","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-024-50450-6","volume":"15","author":"CY Liao","year":"2024","unstructured":"Liao CY, Li G, Kang FP, Lin CF, Xie CK, Wu YD, et al. Necroptosis enhances \u2018don\u2019t eat me\u2019 signal and induces macrophage extracellular traps to promote pancreatic cancer liver metastasis. Nat Commun. 2024;15(1):6043.","journal-title":"Nat Commun"},{"issue":"6586","key":"2529_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"1","key":"2529_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523.","journal-title":"Nat Commun"},{"issue":"10242","key":"2529_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020;395(10242):2008\u201320.","journal-title":"Lancet"},{"issue":"6","key":"2529_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101314","volume":"297","author":"M Grasso","year":"2021","unstructured":"Grasso M, Bond GJ, Kim YJ, Boyd S, Matson Dzebo M, Valenzuela S, et al. The copper chaperone CCS facilitates copper binding to MEK1\/2 to promote kinase activation. J Biol Chem. 2021;297(6):101314.","journal-title":"J Biol Chem"},{"issue":"7","key":"2529_CR16","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1128\/MCB.05722-11","volume":"32","author":"ML Turski","year":"2012","unstructured":"Turski ML, Brady DC, Kim HJ, Kim BE, Nose Y, Counter CM, et al. A novel role for copper in Ras\/mitogen-activated protein kinase signaling. Mol Cell Biol. 2012;32(7):1284\u201395.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"2529_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41568-021-00417-2","volume":"22","author":"EJ Ge","year":"2022","unstructured":"Ge EJ, Bush AI, Casini A, Cobine PA, Cross JR, DeNicola GM, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22(2):102\u201313.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2529_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388.","journal-title":"Nat Rev Clin Oncol"},{"issue":"7501","key":"2529_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature13180","volume":"509","author":"DC Brady","year":"2014","unstructured":"Brady DC, Crowe MS, Turski ML, Hobbs GA, Yao X, Chaikuad A, et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 2014;509(7501):492\u20136.","journal-title":"Nature"},{"key":"2529_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2025.03.031","author":"G Lei","year":"2025","unstructured":"Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell. 2025. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.031.","journal-title":"Cancer Cell"},{"issue":"1","key":"2529_CR21","doi-asserted-by":"publisher","first-page":"18514","DOI":"10.1038\/s41598-022-22962-y","volume":"12","author":"Y Xie","year":"2022","unstructured":"Xie Y, Zhang W, Sun J, Sun L, Meng F, Yu H. A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma. Sci Rep. 2022;12(1):18514.","journal-title":"Sci Rep"},{"issue":"2","key":"2529_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncb1676","volume":"10","author":"JY Yang","year":"2008","unstructured":"Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol. 2008;10(2):138\u201348.","journal-title":"Nat Cell Biol"},{"key":"2529_CR23","doi-asserted-by":"crossref","unstructured":"Xie W, Zhang L, Jiao H, Guan L, Zha J, Li X, et al. Chaperone-mediated autophagy prevents apoptosis by degrading BBC3\/PUMA. Autophagy. 2015;11(9):1623\u201335.","DOI":"10.1080\/15548627.2015.1075688"},{"issue":"2","key":"2529_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.molcel.2022.12.002","volume":"83","author":"L Wang","year":"2023","unstructured":"Wang L, Cai J, Zhao X, Ma L, Zeng P, Zhou L, et al. Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy. Mol Cell. 2023;83(2):281\u201397. e10.","journal-title":"Mol Cell"},{"key":"2529_CR25","doi-asserted-by":"crossref","unstructured":"Kaushik S, Cuervo AM. The coming of age of chaperone-mediated autophagy. Nat Rev Mol Cell Biol. 2018;19(6):365\u201381.","DOI":"10.1038\/s41580-018-0001-6"},{"key":"2529_CR26","doi-asserted-by":"crossref","unstructured":"Kaushik S, Cuervo AM. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012;22(8):407\u201317.","DOI":"10.1016\/j.tcb.2012.05.006"},{"issue":"2 Pt 1","key":"2529_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1078-0432.CCR-06-0964","volume":"13","author":"A Berkenblit","year":"2007","unstructured":"Berkenblit A, Eder JP Jr., Ryan DP, Seiden MV, Tatsuta N, Sherman ML, et al. Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors. Clin Cancer Res. 2007;13(2 Pt 1):584\u201390.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"2529_CR28","doi-asserted-by":"publisher","first-page":"e2212267","DOI":"10.1002\/adma.202212267","volume":"35","author":"B Guo","year":"2023","unstructured":"Guo B, Yang F, Zhang L, Zhao Q, Wang W, Yin L, et al. Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with alphaPD-L1 for enhanced cancer immunotherapy. Adv Mater. 2023;35(22):e2212267.","journal-title":"Adv Mater"},{"issue":"5","key":"2529_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411122","volume":"12","author":"H Wu","year":"2025","unstructured":"Wu H, Lu X, Hu Y, Baatarbolat J, Zhang Z, Liang Y, et al. Biomimic nanodrugs overcome tumor immunosuppressive microenvironment to enhance cuproptosis\/chemodynamic-induced cancer immunotherapy. Adv Sci. 2025;12(5):e2411122.","journal-title":"Adv Sci"},{"issue":"23","key":"2529_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401047","volume":"11","author":"H Wu","year":"2024","unstructured":"Wu H, Zhang Z, Cao Y, Hu Y, Li Y, Zhang L, et al. A self-amplifying ROS-responsive nanoplatform for simultaneous cuproptosis and cancer immunotherapy. Adv Sci. 2024;11(23):e2401047.","journal-title":"Adv Sci"},{"issue":"1","key":"2529_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41(1):271.","journal-title":"J Exp Clin Cancer Res"},{"key":"2529_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102891","volume":"67","author":"J Gao","year":"2023","unstructured":"Gao J, Wu X, Huang S, Zhao Z, He W, Song M. Novel insights into anticancer mechanisms of elesclomol: more than a prooxidant drug. Redox Biol. 2023;67:102891.","journal-title":"Redox Biol"},{"issue":"3","key":"2529_CR33","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1021\/acs.chemrev.0c01029","volume":"121","author":"W Liang","year":"2021","unstructured":"Liang W, Wied P, Carraro F, Sumby CJ, Nidetzky B, Tsung CK, et al. Metal-organic framework-based enzyme biocomposites. Chem Rev. 2021;121(3):1077\u2013129.","journal-title":"Chem Rev"},{"issue":"20","key":"2529_CR34","doi-asserted-by":"publisher","first-page":"12278","DOI":"10.1021\/acs.chemrev.1c00243","volume":"121","author":"G Cai","year":"2021","unstructured":"Cai G, Yan P, Zhang L, Zhou H-C, Jiang H-L. Metal\u2013organic framework-based hierarchically porous materials: synthesis and applications. Chem Rev. 2021;121(20):12278\u2013326.","journal-title":"Chem Rev"},{"issue":"12","key":"2529_CR35","doi-asserted-by":"publisher","first-page":"8228","DOI":"10.1021\/jacs.3c13165","volume":"146","author":"Q Wang","year":"2024","unstructured":"Wang Q, Li X, Cao Z, Feng W, Chen Y, Jiang D. Enzyme-mediated bioorthogonal cascade catalytic reaction for metabolism intervention and enhanced ferroptosis on neuroblastoma. J Am Chem Soc. 2024;146(12):8228\u201341.","journal-title":"J Am Chem Soc"},{"issue":"10","key":"2529_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202215307","volume":"62","author":"B Ding","year":"2023","unstructured":"Ding B, Chen H, Tan J, Meng Q, Zheng P, Ma P, et al. ZIF-8 nanoparticles evoke pyroptosis for high-efficiency cancer immunotherapy. Angew Chem Int Ed Engl. 2023;62(10):e202215307.","journal-title":"Angew Chem Int Ed Engl"},{"key":"2529_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.actbio.2022.04.003","volume":"145","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Zhang C, Du D, Li Y, Sun L, Han Y, et al. Metal-organic framework-based hydrogel with structurally dynamic properties as a stimuli-responsive localized drug delivery system for cancer therapy. Acta Biomater. 2022;145:43\u201351.","journal-title":"Acta Biomater"},{"issue":"1","key":"2529_CR38","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1038\/s41467-023-38605-3","volume":"14","author":"X Xiao","year":"2023","unstructured":"Xiao X, Shi J, He C, Bu X, Sun Y, Gao M, et al. ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. Nat Commun. 2023;14(1):2859.","journal-title":"Nat Commun"},{"issue":"9","key":"2529_CR39","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00262-017-2005-z","volume":"66","author":"N Chen","year":"2017","unstructured":"Chen N, Fang W, Lin Z, Peng P, Wang J, Zhan J, et al. KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma. Cancer Immunol Immunother. 2017;66(9):1175\u201387.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2529_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-021-01972-0","volume":"40","author":"H Zhang","year":"2021","unstructured":"Zhang H, Qin G, Zhang C, Yang H, Liu J, Hu H, et al. TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas. J Exp Clin Cancer Res. 2021;40(1):209.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2529_CR41","doi-asserted-by":"publisher","first-page":"669","DOI":"10.20892\/j.issn.2095-3941.2021.0137","volume":"19","author":"P Ma","year":"2021","unstructured":"Ma P, Jin X, Fan Z, Wang Z, Yue S, Wu C, et al. Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin\/BRAF\/TAK1\/ERK\/ETV4 signaling. Cancer Biol Med. 2021;19(5):669\u201384.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"2529_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0200-4","volume":"5","author":"M Luo","year":"2020","unstructured":"Luo M, Wang F, Zhang H, To KKW, Wu S, Chen Z, et al. Mitomycin C enhanced the efficacy of PD-L1 blockade in non-small cell lung cancer. Signal Transduct Target Ther. 2020;5(1):141.","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"2529_CR43","doi-asserted-by":"publisher","first-page":"R877","DOI":"10.1016\/j.cub.2011.09.040","volume":"21","author":"RA Festa","year":"2011","unstructured":"Festa RA, Thiele DJ. Copper: an essential metal in biology. Curr Biol. 2011;21(21):R877\u201383.","journal-title":"Curr Biol"},{"key":"2529_CR44","doi-asserted-by":"crossref","unstructured":"Denoyer D, Masaldan S, La Fontaine S, Cater MA. Targeting copper in cancer therapy: 'Copper That Cancer'. Metallomics. 2015;7(11):1459\u201376.","DOI":"10.1039\/C5MT00149H"},{"key":"2529_CR45","doi-asserted-by":"crossref","unstructured":"Lossow K, Schwarz M, Kipp AP. Are trace element concentrations suitable biomarkers for the diagnosis of cancer? Redox Biol. 2021;42:101900.","DOI":"10.1016\/j.redox.2021.101900"},{"key":"2529_CR46","doi-asserted-by":"crossref","unstructured":"Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Elem Res. 2017;175(1):57\u201364.","DOI":"10.1007\/s12011-016-0768-2"},{"key":"2529_CR47","doi-asserted-by":"crossref","unstructured":"Khanna SS, Karjodkar FR. Circulating immune complexes and trace elements (Copper, Iron and Selenium) as markers in oral precancer and cancer : a randomised, controlled clinical trial. Head Face Med. 2006;2:33.","DOI":"10.1186\/1746-160X-2-33"},{"key":"2529_CR48","doi-asserted-by":"crossref","unstructured":"Saleh SAK, Adly HM, Abdelkhaliq AA, Nassir AM. Serum Levels of Selenium, Zinc, Copper, Manganese, and Iron in Prostate Cancer Patients. Curr Urol. 2020;14(1):44\u20139.","DOI":"10.1159\/000499261"},{"key":"2529_CR49","doi-asserted-by":"crossref","unstructured":"Feng JF, Lu L, Zeng P, Yang YH, Luo J, Yang YW, Wang D. Serum total oxidant\/antioxidant status and trace element levels in breast cancer patients. Int J Clin Oncol. 2012;17(6):575\u201383.","DOI":"10.1007\/s10147-011-0327-y"},{"issue":"3","key":"2529_CR50","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/cdd.2009.132","volume":"17","author":"ZX Chen","year":"2010","unstructured":"Chen ZX, Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ. 2010;17(3):408\u201320.","journal-title":"Cell Death Differ"},{"issue":"1","key":"2529_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02192-0","volume":"10","author":"Z Guo","year":"2025","unstructured":"Guo Z, Chen D, Yao L, Sun Y, Li D, Le J, et al. The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer. Signal Transduct Target Ther. 2025;10(1):149.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2529_CR52","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s42003-021-02893-6","volume":"5","author":"S Wang","year":"2022","unstructured":"Wang S, Luke CJ, Pak SC, Shi V, Chen L, Moore J, et al. SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation. Commun Biol. 2022;5(1):46.","journal-title":"Commun Biol"},{"key":"2529_CR53","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcdb.2016.09.005","volume":"62","author":"Y Sun","year":"2017","unstructured":"Sun Y, Sheshadri N, Zong WX. SERPINB3 and B4: from biochemistry to biology. Semin Cell Dev Biol. 2017;62:170\u20137.","journal-title":"Semin Cell Dev Biol"},{"key":"2529_CR54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163841","author":"L Chen","year":"2023","unstructured":"Chen L, Shi V, Wang S, Sun L, Freeman R, Yang J, et al. SCCA1\/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI163841.","journal-title":"J Clin Invest"},{"key":"2529_CR55","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/ncomms4729","volume":"5","author":"JM Catanzaro","year":"2014","unstructured":"Catanzaro JM, Sheshadri N, Pan JA, Sun Y, Shi C, Li J, et al. Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3\/B4. Nat Commun. 2014;5:3729.","journal-title":"Nat Commun"},{"issue":"1","key":"2529_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia P, Khorramdelazad H, Nickho H, Delbandi AA. Current and future immunotherapeutic approaches in pancreatic cancer treatment. J Hematol Oncol. 2024;17(1):40.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"2529_CR57","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: a review. JAMA. 2021;326(9):851\u201362.","journal-title":"JAMA"},{"issue":"9","key":"2529_CR58","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","volume":"17","author":"WJ Ho","year":"2020","unstructured":"Ho WJ, Jaffee EM, Zheng L. The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nat Rev Clin Oncol. 2020;17(9):527\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2529_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308241","volume":"36","author":"L Qiao","year":"2024","unstructured":"Qiao L, Zhu G, Jiang T, Qian Y, Sun Q, Zhao G, et al. Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors. Adv Mater. 2024;36(8):e2308241.","journal-title":"Adv Mater"},{"issue":"13","key":"2529_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309388","volume":"11","author":"F Hu","year":"2024","unstructured":"Hu F, Huang J, Bing T, Mou W, Li D, Zhang H, et al. Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy. Adv Sci (Weinh). 2024;11(13):e2309388.","journal-title":"Adv Sci (Weinh)"},{"issue":"18","key":"2529_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202309984","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu X, Chen X, Lin C, Yi Y, Zhao S, Zhu B, et al. Elesclomol loaded copper oxide nanoplatform triggers cuproptosis to enhance antitumor immunotherapy. Adv Sci. 2024;11(18):e2309984.","journal-title":"Adv Sci"},{"key":"2529_CR62","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jconrel.2024.06.059","volume":"372","author":"H Zafar","year":"2024","unstructured":"Zafar H, Zhang J, Raza F, Pan X, Hu Z, Feng H, et al. Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. J Control Release. 2024;372:446\u201366.","journal-title":"J Control Release"},{"key":"2529_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.101911","author":"Q-X Huang","year":"2023","unstructured":"Huang Q-X, Liang J-L, Chen Q-W, Jin X-K, Niu M-T, Dong C-Y, et al. Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma. Nano Today. 2023. https:\/\/doi.org\/10.1016\/j.nantod.2023.101911.","journal-title":"Nano Today"},{"key":"2529_CR64","doi-asserted-by":"crossref","unstructured":"Su Y, Wei F, Li S, Qi J, Lin G, Li G, et al. Cingulin is an RNA-binding proteinpromoting pancreatic cancer through enhancing importin 7-mediated phospho-ERKnuclear translocation. Cell Rep. 2025;44(7):115925.","DOI":"10.1016\/j.celrep.2025.115925"},{"key":"2529_CR65","doi-asserted-by":"crossref","unstructured":"Qin C, Zhao B, Wang Y, Li Z, Li T, Zhao Y, et al. Extracellular vesicles miR-31-5ppromotes pancreatic cancer chemoresistance via regulating LATS2-Hippo pathway andpromoting SPARC secretion from pancreatic stellate cells. J Extracell Vesicles.2024;13(8):e12488.","DOI":"10.1002\/jev2.12488"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02529-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02529-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:45:27Z","timestamp":1772451927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02529-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2529"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02529-x","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"9 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human PDAC tissues obtained from Fujian Provincial Hospital and Fujian Medical University Union Hospital were utilized for IHC analysis, PDOs establishment, mIFS, and scRNA-seq investigations. Technical execution of mIFS was conducted by Wuhan Servicebio Technology Co., Ltd. (Wuhan, China). This study protocol received ethical approval from the Institutional Review Board of Fujian Provincial Hospital (IRB No. K2024-06-027), with written informed consent obtained from all participating donors. Animal experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee of Fujian Provincial Hospital (Protocol No. IACUC-FPH-SL-20240530[0312]) and strictly adhered to the National Institutes of Health (NIH) Guidelines for the Humane Use and Care of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors understand that the text and any pictures or videos published in the article will be freely available on the internet and may be seen by the general public. The pictures, videos and text may also appear on other websites or in print, may be translated into other languages or used for commercial purposes. The authors have been offered the opportunity to read the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}